NEW YORK, Jan. 30, 2024 /PRNewswire/ -- The sinus dilation devices market size is estimated to grow by USD 1.50 billion from 2022 to 2027 at a CAGR of 8.54% according to Technavio. The Balloon Sinus Dilation segment is poised for substantial growth in the Sinus Dilation Devices Market, driven by its effectiveness and safety in treating chronic sinusitis. This less invasive procedure offers faster recovery rates compared to traditional surgeries, as it does not involve bone or tissue removal. Utilizing a flexible balloon catheter, opens blocked sinus passageways, aiding mucus drainage. These advantages propel the segment's expansion amidst growing demand for minimally invasive sinus treatments. To understand more about the Market, request a Free sample report
Sinus Dilation Devices Market Insights -
- Vendors: 15+, Including Accurate Surgical and Scientific Instruments Corp., Aetna Inc., B. Braun SE, Creganna Medical Unlimited, Dalent LLC, EMOS Technology GmbH, ESC Medicams, InnAccel Technologies Pvt. Ltd., Intersect ENT Inc., KARL STORZ SE and Co. KG, Medtronic Plc, Meril Life Sciences Pvt. Ltd., Olympus Corp., Optim LLC, SinuSys Corp., Sklar Surgical Instruments, Smith and Nephew plc, Stryker Corp., Summit Medical LLC, Johnson and Johnson, among others
- Coverage: Parent market analysis; key drivers, major trends, and challenges; customer and vendor landscape; vendor product insights and recent developments; key vendors; and market positioning of vendors
- Segments: Product (Balloon sinus dilation devices, Endoscopes, Surgical instruments, and Sinus stents), Application (Standalone sinus dilation and Hybrid sinus dilation), and Geography (North America, Europe, Asia, and Rest of World (ROW))
The growing competition is compelling vendors to adopt various growth strategies such as promotional activities and spending on advertisements to improve the visibility of their services. Technavio's report analyzes the competitive landscape and offers information on several vendors.
- The high prevalence of chronic sinusitis globally is a major driver of the Market. With increasing cases across all age groups, particularly in the US, where it affects a significant portion of the population, there's a growing need for effective treatment options. Traditional approaches may not provide complete symptom relief, leading to demand for alternative or adjunctive treatments, fostering growth during the forecast period.
- The growth of healthcare infrastructure is an emerging trend fueling the growth, however, the presence of alternative treatments challenges the growth.
Drivers, & Challenges have an impact on dynamics and can impact businesses. Find some insights from a free sample report!
The report provides critical information and factual data, with a qualitative and quantitative study based on drivers and limitations as well as future prospects.
Why Buy?
- Add credibility to strategy
- Analyzes competitor's offerings
- Get a holistic view
Grow your profit margin with Technavio- Buy the Report
What are the key data covered in this report?
- CAGR during the forecast period
- Detailed information on factors that will drive the growth between 2023 and 2027
- Precise estimation of the size and its contribution to parent market
- Accurate predictions about upcoming trends and changes in consumer behavior
- Growth of the industry across North America, Europe, Asia, and Rest of World (ROW)
- A thorough analysis of the competitive landscape and detailed information about vendors
- Comprehensive analysis of factors that will challenge the growth of vendors
Technavio's SUBSCRIPTION platform
Applications
The industry offers solutions for chronic treatment, including Balloon Sinus Dilation. With a focus on anatomy and ventilation, devices target ostia in maxillary, ethmoid, frontal, and sphenoid sinuses. Addressing symptoms like congestion and headaches, these devices aim to improve sinus drainage and reduce inflammation. As prevalence rises globally, demand increases for effective management options, driving innovation and surgery.
Related Reports:
The global sinusitis drugs market size is estimated to grow by USD 801.39 million between 2022 and 2027 accelerating at a CAGR of 6.23%.
The sinuscope endoscopes market share is expected to increase by USD 88.69 million from 2021 to 2026, and the growth momentum will accelerate at a CAGR of 7.8%.
ToC
1 Executive Summary
2 Landscape
3 Sizing
4 Historic Size
5 Five Forces Analysis
6 Segmentation by Product
7 Segmentation by Application
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
About US
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging trends and provide actionable insights to help businesses identify opportunities and develop effective strategies to optimize their positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable insights to identify opportunities in existing and potential markets and assess their competitive positions within changing scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com
SOURCE Technavio
![](https://rt.prnewswire.com/rt.gif?NewsItemId=CG24221&Transmission_Id=202401302315PR_NEWS_USPR_____CG24221&DateId=20240130)
Share this article